Found: 99
Select item for more details and to access through your institution.
Evaluation of dermatological conditions: the diagnostic potential of artificial intelligence in primary care.
- Published in:
- Clinical & Experimental Dermatology, 2024, v. 49, n. 7, p. 737, doi. 10.1093/ced/llad423
- By:
- Publication type:
- Article
Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 6, p. 917, doi. 10.1093/bjd/ljae056
- By:
- Publication type:
- Article
Beautiful Bias from ChatGPT.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2024, v. 17, n. 6, p. 10
- By:
- Publication type:
- Article
A large language model artificial intelligence for patient queries in atopic dermatitis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. e531, doi. 10.1111/jdv.19737
- By:
- Publication type:
- Article
Combined Biologic and Surgical Interventions for Hidradenitis Suppurativa: A Systematic Review.
- Published in:
- Dermatologic Therapy, 2024, v. 2024, p. 1, doi. 10.1155/2024/6637006
- By:
- Publication type:
- Article
Topical steroids or emollients: does order matter?
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 4, p. 1, doi. 10.1007/s00403-024-02837-0
- By:
- Publication type:
- Article
Conjunctivitis does not increase with longer duration of lebrikizumab exposure in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii5, doi. 10.1093/bjd/ljad498.007
- By:
- Publication type:
- Article
Lebrikizumab in combination with topical corticosteroids maintains improvements in itch and sleep at 68 weeks in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii6, doi. 10.1093/bjd/ljad498.008
- By:
- Publication type:
- Article
Tralokinumab real-world patient-reported outcomes in moderate-to-severe atopic dermatitis adult patients in the United States: 6-month interim analysis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii50, doi. 10.1093/bjd/ljad498.052
- By:
- Publication type:
- Article
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 2, p. 289, doi. 10.1093/bjd/ljad435
- By:
- Publication type:
- Article
Is Food-Triggered Atopic Dermatitis a Form of Systemic Contact Dermatitis?
- Published in:
- Clinical Reviews in Allergy & Immunology, 2024, v. 66, n. 1, p. 1, doi. 10.1007/s12016-023-08977-x
- By:
- Publication type:
- Article
Association between atopic dermatitis and illicit drug use among US adults.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 12, p. e637, doi. 10.1111/ijd.16772
- By:
- Publication type:
- Article
Photobiomodulation therapy and low-level light therapy in wound healing.
- Published in:
- Lasers in Medical Science, 2023, v. 38, n. 1, p. 1, doi. 10.1007/s10103-023-03909-9
- By:
- Publication type:
- Article
Treatment of Dystrophic Epidermolysis Bullosa Pruriginosa: A Systematic Review of Clinical Outcomes after Initiation of Dupilumab Therapy.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/3863357
- By:
- Publication type:
- Article
Atopic Dermatitis: Beyond the Skin and Into the Gut.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 17, p. 5534, doi. 10.3390/jcm12175534
- By:
- Publication type:
- Article
From eczema to anxiety: How artificial intelligence shapes parental perspectives.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 5, p. 964, doi. 10.1111/pde.15417
- By:
- Publication type:
- Article
A response to "Steroid phobia on social media platforms".
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 5, p. 968, doi. 10.1111/pde.15373
- By:
- Publication type:
- Article
Identifying prevalence and inpatient outcomes of anemia and hidradenitis suppurativa.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 5, p. 1287, doi. 10.1007/s00403-022-02515-z
- By:
- Publication type:
- Article
Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2039, doi. 10.1111/bcp.15751
- By:
- Publication type:
- Article
Effects of sun protection on serum vitamin D deficiency.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2023, v. 39, n. 4, p. 394, doi. 10.1111/phpp.12838
- By:
- Publication type:
- Article
The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair.
- Published in:
- Skin Pharmacology & Physiology, 2023, v. 36, n. 4, p. 174, doi. 10.1159/000534136
- By:
- Publication type:
- Article
399 Pooled safety analysis of lebrikizumab in patients with uncontrolled asthma from three randomized clinical trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.022
- By:
- Publication type:
- Article
413 Improvement in itch, symptoms and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (Measure Up 1, Measure Up 2 and AD Up).
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.033
- By:
- Publication type:
- Article
409 Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase 3 clinical trials at 52 weeks.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.030
- By:
- Publication type:
- Article
380 Patients maintain stable response with no or minimal fluctuations during treatment with lebrikizumab up to Week 52.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.008
- By:
- Publication type:
- Article
427 Long-term 4-year safety of upadacitinib in moderate-to-severe atopic dermatitis: results of an integrated analysis of phase 3 studies.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.047
- By:
- Publication type:
- Article
Atopic eczema patients and healthcare professionals join forces in Malta.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 404, doi. 10.1002/jvc2.156
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 5, p. 526, doi. 10.1001/jamadermatol.2023.0391
- By:
- Publication type:
- Article
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic Review.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 3, p. 320, doi. 10.1001/jamadermatol.2022.6045
- By:
- Publication type:
- Article
321 Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: systematic review and Bayesian meta-analysis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii12, doi. 10.1093/bjd/ljac140.017
- By:
- Publication type:
- Article
326 Dupilumab: a comparison of infection rates across atopic dermatitis trials in adults, adolescents, children and infants.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii15, doi. 10.1093/bjd/ljac140.021
- By:
- Publication type:
- Article
Integrative Approaches to Sleep Management in Skin Disease: Systematic Review.
- Published in:
- JMIR Dermatology, 2023, v. 6, n. 1, p. 478, doi. 10.2196/48713
- By:
- Publication type:
- Article
Biologics and Small Molecule Inhibitors: an Update in Therapies for Allergic and Immunologic Skin Diseases.
- Published in:
- Current Allergy & Asthma Reports, 2022, v. 22, n. 12, p. 183, doi. 10.1007/s11882-022-01047-w
- By:
- Publication type:
- Article
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 6, p. 755, doi. 10.1007/s40257-022-00714-y
- By:
- Publication type:
- Article
Dietary Triggers for Atopic Dermatitis in Children.
- Published in:
- Cutis, 2022, v. 110, n. 5, p. 264, doi. 10.12788/cutis.0640
- By:
- Publication type:
- Article
A quality assessment of YouTube videos on sclerosing disorders.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 9, p. e360, doi. 10.1111/ijd.15810
- By:
- Publication type:
- Article
EXPERT PERSPECTIVES.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2022, v. 15, n. 9, p. 13
- By:
- Publication type:
- Article
Algorithm‐based readability assessment of online patient educational material for erythropoietic protoporphyria.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 8, p. e317, doi. 10.1111/ijd.15825
- By:
- Publication type:
- Article
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1337, doi. 10.1007/s13555-022-00731-z
- By:
- Publication type:
- Article
Patch Testing on Dupilumab: Reliable or Not?
- Published in:
- Cutis, 2022, v. 109, n. 3, p. 158, doi. 10.12788/cutis.0471
- By:
- Publication type:
- Article
Myths and media in oral collagen supplementation for the skin, nails, and hair: A review.
- Published in:
- Journal of Cosmetic Dermatology, 2022, v. 21, n. 2, p. 438, doi. 10.1111/jocd.14567
- By:
- Publication type:
- Article
The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 1, p. 27, doi. 10.1007/s40257-021-00647-y
- By:
- Publication type:
- Article
Efficacy and safety of crisaborole in patients with mild-tomoderate atopic dermatitis and other atopic comorbidities.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 5, p. 425, doi. 10.2500/aap.2021.42.210064
- By:
- Publication type:
- Article
Epidermolysis bullosa on YouTube: a cross‐sectional analysis.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 9, p. e358, doi. 10.1111/ijd.15435
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety and Sourcing of Topical Cannabinoids: Many Questions, Few Answers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A new era of moisturizers.
- Published in:
- Journal of Cosmetic Dermatology, 2021, v. 20, n. 8, p. 2425, doi. 10.1111/jocd.14217
- By:
- Publication type:
- Article
Differences in pediatric versus adult clinical trial characteristics for atopic dermatitis.
- Published in:
- Pediatric Dermatology, 2021, v. 38, n. 4, p. 775, doi. 10.1111/pde.14658
- By:
- Publication type:
- Article
Readability of online patient education materials for juvenile dermatomyositis.
- Published in:
- Pediatric Dermatology, 2021, v. 38, n. 2, p. 544, doi. 10.1111/pde.14513
- By:
- Publication type:
- Article
Pandemic Pressure: Teledermatology and Health Care Disparities.
- Published in:
- Journal of Patient Experience, 2021, v. 8, p. 1, doi. 10.1177/2374373521996982
- By:
- Publication type:
- Article